Back

Echo is the only modality needed for anthracycline cardiotoxicity.

27 May 2017 (10:09 - 10:21)
Organised by:
Congress Presentation Part of: CMR in Special Patient Populations Cardiac Magnetic Resonance EACVI Premium Access EuroCMR 2017

About the speaker

Photo
Professor Juan Carlos Plana

Thomas Jefferson University, Philadelphia (United States of America)

4 More presentations in this session

Presentation thumbnail
CMR is the only modality needed for anthracycline cardiotoxicity.
Professor C. Manisty (London, GB)
Slides
Presentation thumbnail
CMR and transplantation.
Doctor C. Miller (Manchester, GB)
Slides
Presentation thumbnail
CMR in rheumatology.
Professor N. Ntusi (Cape Town, ZA)
Slides
Presentation thumbnail
CMR of the aging heart.
Assistant Professor E. Schelbert
Slides

Access the full session

Session thumbnail
CMR in Special Patient Populations

The Event

Event poster

EuroCMR 2017

27 May 2017 10:09 CET
You may be interested in
thumbnail
Congress Presentation
Relationship between clinical and echocardiographic outcomes and cardioprotective drugs in a population of female breast cancer patients exposed to anthracyclines
21 May 2023
thumbnail
Congress Presentation
Cardiac computed tomography and magnetic resonance for precision diagnosis and monitoring for better outcome
1 September 2025
thumbnail
Congress Presentation
Comparison of cardiac magnetic resonance imaging and echocardiography for early definition of chemotherapeutic cardiotoxicity in children and adolescents: a systematic review and meta-analysis
31 August 2025
thumbnail
Congress Session
New insights into cancer therapy-related cardiac dysfunction
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources